éå»1ã¶æéã«Anika Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã2åã«åºã¥ãããŒã¿ã
仿ãANIKã¯1ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããANIKã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯23.000ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 0.248ã«ç¶ããANIKã®FY2026Q3ã®EPSã¯0.060ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.25 ã§ããããAnika Therapeutics IncANIK ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.37 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD 0.06 ãšäºæ³ãããŸãã